Article info

Download PDFPDF
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease

Authors

  1. Correspondence to Rachel S Simpson, Toronto Allergists, Toronto, ON M5G 1E2, Canada; rachel.simpson{at}queensu.ca
View Full Text

Citation

Simpson RS, Lau SKC, Lee JK
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease

Publication history

  • Received September 24, 2019
  • Revised December 10, 2019
  • Accepted December 11, 2019
  • First published December 19, 2019.
Online issue publication 
March 19, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.